We have constructed a series of mutants with deletion, linker insertion, and point mutations in the v-crk oncogene of avian sarcoma virus CT10. The v-crk gene contains no apparent catalytic domain, but does contain two blocks of homology to putative regulatory domains, termed SH2 and SH3, found in a variety of proteins implicated in signal transduction. Infection with CT10 causes a dramatic increase in the level of tyrosine phosphorylation of several cellular proteins. We found that mutation of either the SH2 or SH3 domain of v-crk reduced or eliminated transforming activity, whereas mutation of regions outside the conserved domains had no effect. Deletion of amino-terminal gag sequences caused a partial loss of transforming activity and a change in subceliular distribution of the crk protein. In all cases, there was an absolute correlation between increased cellular phosphotyrosine and transformation.
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The crk oncogene of avian sarcoma virus CT10 encodes a 47-kilodalton (kDa) gag fusion product, termed p47gag-crk (20) . A second crk-encoding avian sarcoma virus was recently described that has a genetic structure very similar to CT10 (33) . Although the v-crk gene has no sequence similarity to any known catalytic domain, it contains two blocks of sequence, the SH2 and SH3 domains, which are found in a wide variety of proteins. These domains are thought to regulate the activity of proteins in which they are found, perhaps by interacting with catalytic domains or with other cellular proteins (21a, 24) .
The SH2 domain (the B and C boxes of Stahl et al. [29] ) is composed of one region of approximately 50 amino acids (B box) and a second region of 10 amino acids (SH2' or C box) separated by a variable region. It was originally identified as a common N-terminal domain in all nonreceptor proteintyrosine kinases (28) and was subsequently found in two isoforms of phosphatidylinositol-specific phospholipase C (PLD-,y and PLC-IV) (10, 29, 30) and the ras GTPase activator protein (32, 34) , as well as v-crk. The SH3 domain (A box), consisting of approximately 50 amino acids, is found in a wider variety of proteins, including most nonreceptor tyrosine kinases; PLC-y and PLC-IV; the GTPase activator protein; the cytoskeletal matrix proteins fodrin, myosin-I, and actin-binding protein ABPlb; the Saccharomyces cerevisiae proteins Cdc25 and Fusl, and neutrophil cytosolic oxidase factor p47 (9, 18, 24, 27) . Whenever enzymatic activity has been examined (in the case of the tyrosine kinases, PLCs, and the GTPase activator protein), the SH2 and SH3 domains have been shown to be unnecessary (2, 3, 10, 17, 19) . Since the SH2 and SH3 domains are found independently in at least one protein and are present in various combinations in others, we presume that they have modular and independent functions. CT10-transformed cells have greatly elevated phosphotyrosine levels on at least three cellular proteins compared with normal control cells (20) . We have shown that p47gag-crk can tightly associate with these phosphotyrosine-containing proteins (21, 21a) and that tyrosine kinase and serinethreonine kinase activity also coimmunoprecipitate with p47gag-crk (20, 21, 21a) . These data led us to propose a model in which the v-crk product increases tyrosine phosphorylation of cellular substrate proteins by mediating the formation of ternary complexes consisting of P47gagcrk, substrate proteins, and endogenous protein kinases (21a) .
We have constructed a series of mutant v-crk genes to determine which domains of the protein are required for transforming activity and to correlate transforming activity with biochemical parameters in mutant-infected cells. We present evidence that the SH2, SH2', and SH3 domains are all required for full transforming activity and that N-terminal gag sequences also contribute to transforming activity, presumably by affecting subcellular localization. In all cases, increased cellular phosphotyrosine correlated with transforming activity, suggesting that this increase is central to the mechanism of transformation by v-crk.
MATERIALS AND METHODS
Cells and virus. Chicken embryo fibroblasts (CEF) were prepared and maintained essentially as described previously (14) . Virus stocks were prepared by cutting pCT10 or its derivatives with ScaI, mixing with SstI-cleaved pUR2AV helper virus DNA (22) , ligating briefly, and transfecting 1 ,ug of each plasmid per 6-cm dish of CEF by calcium phosphate coprecipitation (6, 36) . Stocks of Rous sarcoma virus (RSV)-derived mutant viruses were prepared as described previously (6, 16) . Transfected cells were routinely maintained in medium containing 0.375% agar at 40°C. CEF transfected with wild-type (wt) pCT10 were generally fully transformed by the third passage (12 to 14 days posttransfection).
To assay anchorage independence, CEF were trypsinized 2 days posttransfection and 106 cells were plated per 10-cm bacterial plastic dish in 10 ml of medium containing 11% calf serum, 1% chicken serum, and 0.4% agar on a layer of 15 Tumorigenicity was assayed by injection of 0.1 ml of virus in each wing web of newborn (2 to 5 days posthatching) white leghorn chickens (SPAFAS, Inc.). To coculture tumor cells, tumor tissue was minced and then incubated with 0.25% trypsin in buffered isotonic saline at 37°C with gentle shaking for 20 min. Dissociated cells and small clumps were poured off, pelleted, and added to a feeder layer of freshly plated CEF. Cultures were transferred once to allow virus spread.
Construction of pCT10. A nonpermuted CT10 viral genome was constructed from the original permuted molecular clone, p10-282 (20) , as outlined in Fig. 1 gag-deleted mutants were constructed by using a replication-competent RSV vector system (6). plO-SHB was constructed by ligating the 0.7-kb SfiI-HaeII fragment of pCT10 to a BamHI adaptor (5'-CGGATCCGGCGC-3' plus 5'-CG GATCCGTCA-3'), digesting with BamHI, and ligating to BglII-cleaved pNR200 (16) . plO-NSC was made in two steps. First, hybrid vector pNR111, consisting of the 5.8-kb BglIIClaI fragment of pNR200 ligated to the 1.8-kb ClaI-BglII fragment of pXD11-1 (6) , was constructed. Then the BamHIlinkered 0.8-kb StyI-HaeII fragment of pCT10 was inserted into the BglII site of pNR111 to generate plO-NSC.
Protein analysis. Isotopic labeling, cell lysis, immunoprecipitation, and immunoblotting have been described previously (12, 20, 21a) . Polyclonal rabbit anti-phosphotyrosine serum (anti-ptyr) (12, 35) and anti-crk serum (21a) have been previously described.
Crude membrane (P100) and cytosolic (S100) fractions (Fig. 1 ). This plasmid, pCT10, is the parental plasmid of all the mutants described here. last few amino acids of SH2' (ASH3) was deleted. When convenient restriction sites were available, linker insertion mutants resulting in the in-frame insertion of four or five amino acids were generated. These insertions were in the amino-terminal part of SH3 (BSP), in the region between SH2' and SH3 (MH), within the SH2' block (ESP), and in the region between SH2 and SH2' (SMH). Since there are no convenient restriction sites in SH2, two mutants with point mutations at well-conserved residues within this domain were made by oligonucleotide-directed mutagenesis. The histidine at position 294 was changed to arginine (R294), and the arginine at position 273 was changed to asparagine (N273). The arginine at position 273 is absolutely conserved in all known SH2 domains and is within the very highly conserved FLVRXS hexapeptide. The histidine at position 294 is conserved in all but one SH2 domain and is at the C-terminal boundary of the SH2 homology.
Biological activity of v-crk mutants. The biological activity of the mutants was assayed by transfection of pCT10-derived DNA, along with UR2AV helper virus DNA, into CEF. In this system, expression of the mutant crk gene product is dependent on replication of the mutant CT10 virus. UR2AV DNA is cotransfected to provide essential replicative gene products in trans to the replication-defective CT10-derived virus. Since all mutants contain the same long terminal repeat and cis-acting replicative sequences (except Three criteria for the transforming activity of the mutant crk viruses were assayed: morphological alteration and anchorage-independent growth of infected CEF and tumorigenicity in newborn chickens. Table 1 summarizes these results. The only mutants that retained full transforming activity were SMH and MH, which had linkers inserted into the nonconserved regions between the SH2 and SH2' domains or between the SH2' and SH3 domains. These viruses were indistinguishable from parental CT10 by all criteria examined. The BSP mutant, containing a linker in the SH3 domain, had a very weak transforming phenotype. Infected cells were indistinguishable from helper-infected controls in monolayer culture, but were able to form small colonies in soft agar (Fig. 3) . In addition, one of two chickens (one of four sites) injected with virus developed a small, slowgrowing tumor. Virus recovered from this tumor had the properties of the parental BSP mutant, suggesting that the tumor was induced by the authentic mutant. The remaining mutants had no detectable transforming activity in monolayer culture or agar suspension. The tumorigenic activity of the ESP virus was shown to be due to generation of fully transforming variants, since virus recovered from tumors induced morphological alteration and anchorage-independent growth, unlike the parental mutant.
Since retroviruses generate frequent mutants through replication errors, one often observes either the loss of sequences that are not selected for (such as nontransforming oncogene sequences) or accumulation of mutants that are selected for (changes that activate the transforming potential of nontransforming genes) ( agar suspension 2 days posttransfection (Fig. 3) . At most, one round of viral replication would have occurred by this time, so the effect of mutation is expected to be negligible. The results of this assay were qualitatively similar to those in which later-passage, fully infected cells were used (data not shown). This colony formation assay is also designed to detect anchorage-independent growth of a small number of transformed cells in a large population of normal cells.
Mutant v-crk proteins. We used immunoblotting to examine the level of mutant v-crk proteins expressed in transfected cultures (Fig. 4A) . In all cases except ASH3, mutant protein of the expected molecular weight was observed. The level of expression of nontransforming mutants was lower than that of wt or fully transforming mutants, presumably owing to selection against replication of the nontransforming mutant viruses. We conclude that the lower levels of protein reflect wt levels of expression in a subpopulation of cells, and not lower, perhaps "subthreshold" levels of expression in all cells, for the following reasons. First Phosphotyrosine levels in mutant-transfected CEF were assayed by immunoblotting with anti-ptyr (12, 35) . Phosphotyrosine levels correlated absolutely with transforming activity (Fig. 4B) (Fig. 5 ). This experiment also demonstrates that the mutant crk proteins, like wt p47gag-crk, were highly phosphorylated.
Construction of gag(-) crk mutants. To assess the contribution of viral gag sequences to the biological activity of p47gag-crk, we also constructed two gag-deleted [gag(-)] mutants. For these mutants we used a replication-competent RSV-derived vector (6, 16) in which the truncated crk gene is inserted at the position occupied by the src gene in wildtype RSV. These constructs do not require cotransfection with helper virus to replicate, and should therefore express the mutant crk proteins more efficiently than in the case of the replication-defective, CT10-derived mutants described above.
The two gag(-) constructs have different translation start sites (Fig. 2) . A c-crk cDNA has been cloned, and the sequence revealed that the cellular product initiates at the methionine homologous to methionine 236 of v-crk. The region of v-crk between the gag-crkjunction and methionine 236 is derived from intron and 5' untranslated sequences and is not found in the c-crk product (C. T. Reichman, B. J. Mayer, S. Keshav, and H. Hanafusa, submitted for publication). was constructed to initiate translation with the amino-terminal 14 amino acids of p60src, which are fused to the C-terminal 234 amino acids of v-crk. These 14 src-derived amino acids are sufficient to direct myristoylation of heterologous proteins (25) , so this construct is expected to direct the synthesis of a myristoylated, 252-amino-acid product. Myristoylation is often sufficient to direct tight association of proteins with the plasma membrane (25, 31); we hoped that by using the src amino terminus we could target this gag(-) crk mutant to membranes, as well as take advantage of a translational start site that is known to work efficiently in a retroviral context.
Biological and biochemical properties of gag(-) mutants. The biological properties of these two mutants are summarized in Table 2 . Both mutants had partially transforming phenotypes. The myristoylated NSC mutant induced subtle morphological alteration in monolayer culture and very small colonies in suspension (Fig. 6) , although in both cases it was much less potent than wt CT10 virus. When injected into chickens it induced tumors with high frequency, but when virus was isolated from tumors it was found to be as transforming as wt CT10; furthermore, the tumor-derived crk protein could be shown by immunoblotting and immunoprecipitation to have regained viral gag sequences (data not shown). This was presumably due to deletion of the sequences between gag and crk, in some cases mediated by eight nucleotides of viral gag sequence present in the NSC crk gene. Owing to this recombination, we cannot assess the tumorigenic potential of the authentic NSC mutant, although it must necessarily be less than that of the gag-containing recombinants. The SHB mutant was somewhat more transforming than NSC in both monolayer culture and suspension (Fig. 6) , although still less so than the wt strain. It induced tumors in chickens, but the latency period was longer and the tumors were slower growing than in the case of wt CT10.
No recombination with gag was observed with this mutant, so we assume the tumors were induced by the authentic gag(-) mutant. (Fig. 7) . b Assayed in agar-overlaid monolayer culture after the second passage (Fig. 6) .
c Assayed in agar suspension (Fig. 6) .
d Assayed by injection of each wing web of newborn chickens (number of sites with palpable tumors/total number of sites injected; dpi, days postinjection).
Tumor cocultures were more morphologically altered than the parental NSC cells in monolayer culture; crk protein had recovered gag sequences. f Tumors were relatively slow-growing; cocultures were morphologically similar to parental SUB cells.
The gag(-) mutant proteins were expressed at relatively high levels, comparable to wt p47gag-crk (Fig. 7A) . The levels of phosphotyrosine in cells infected with these mutants, however, were reduced compared with those in wt-infected cells (Fig. 7B) . Although in some experiments the tyrosine phosphorylation of the 135-to 155-and the 120-kDa proteins of NSC-infected cells was comparable to that in the wt strain, the 70-kDa protein phosphotyrosine level was always lower ( Fig. 7B; data not shown) . It was generally difficult to see any elevation of 120-and 135-to 155-kDa protein phosphotyrosine content in SHB-infected cells, although the 70-kDa protein clearly had elevated phosphotyrosine levels relative to controls.
Subcellular distribution of gag(-) mutant proteins. Since mutants NSC and SHB were identical to wt v-crk in the c-crk-derived portion of the gene and since immunoblotting demonstrated that the truncated proteins were expressed at relatively high levels, it was surprising that these mutants were not fully transforming. A likely function for viral gag sequences is to direct the subceilular localization of proteins to which it is fused. We therefore examined the subcellular distribution of wt p47gag-crk and the two gag(-) mutants. The majority of wt p47gag-crk partitions in the crude membrane (P100) fraction, although a significant proportion is found in the cytosolic (S100) fraction (Fig. 8A) . The NSC protein is found almost exclusively in the P100 fraction, similar to many other myristoylated proteins (23, 31) . The upper bands in the NSC lanes are crk proteins from variant viruses that had recombined with helper and recovered N-terminal gag sequences. As expected, labeling of infected cells with [3H]myristic acid demonstrated that the authentic NSC crk protein was myristoylated (data not shown). The SHB protein, in contrast, is almost exclusively cytosolic in distribution (Fig. 8A) . Unlike wt p47gag-crk, therefore, neither of the two gag(-) mutants provides significant amounts of crk protein in boyh the soluble and the membraneassociated compartments.
When the P100 and S100 fractions of CT10-infected cells were analyzed by anti-ptyr immunoblotting, most of the phosphotyrosine-containing proteins were found in the membrane fraction (Fig. 8B) , consistent with previous results with tyrosine kinase oncogenes (13) . The majority of the 70-kDa phosphotyrosine-containing protein, however, was found in the cytosolic fraction. If, as we suspect, binding to crk protein is required for tyrosine phosphorylation of these proteins, these data suggest a role for crk protein in both the membrane and cytosolic compartments.
The results with the two gag(-) mutants were ambiguous. The sum of cytosolic plus membrane phosphoproteins did not give the same pattern as when mutant-infected cells were lysed directly by boiling in sodium dodecyl sulfate (Fig. 7B) (24) . We found that both domains are required for full transformation by v-crk; in contrast, mutation of the spacer regions between these domains had no effect on transforming activity. This result highlights the importance of SH2 and SH3 domains, which may play a central role in mediating the assembly of multiprotein complexes during normal signal transduction (21a, 24; M. Matsuda and H. Hanafusa, submitted for publication).
We have proposed that v-crk might elevate the intracellular phosphotyrosine content of critical cellular proteins by binding in a ternary complex with substrate proteins and endogenous protein-tyrosine kinases (21a) . In this model, it is reasonable to assume that the SH2 and SH3 domains independently bind to either kinases or their substrates, but that both domains are required for assembly of ternary complexes. This is consistent with the mutagenic data presented here and with the sequence data for a number of other proteins, which implies that the SH2 plus SH2' domains and the SH3 domain must have modular and independent functions (24) . Our results are incompatible with a model in which either SH2 or SH3 is solely responsible for the biological activity of v-crk.
The fact that the SH3 linker insertion mutant, BSP, retains some transforming activity could imply that this domain is less critical than SH2 plus SH2' for transformation. However, the linker in this mutant is inserted into a region of the SH3 domain that is extremely variable when other sequences are compared; in fact, the S. cerevisiae cdc25 gene product has a five-amino-acid insertion precisely at the homologous spot in its SH3 domain (1, 27) . This mutation may therefore alter the conformation insufficiently to completley abolish SH3 function. Further mutation of highly conserved SH3 residues is required to resolve this question. In contrast, the total lack of biological activity of the two SH2 point mutants (N273 and R294) inplies a critical function for the mutated residues or an extreme sensitivity to conformational change.
We have found that in all cases the degree of increased cellular phosphotyrosine levels in mutant-infected cells cor-A B CT10 NSC SHB NR200 P S P S P S P S VOL. 64, 1990 on The requirement for retroviral gag sequences for full transforming activity is surprising, since the gag-deleted mutant viruses express high levels of the c-crk-derived portion of v-crk. Retroviral gag has previously been shown to be important for the transforming activity of other oncogenes, including abl andfps, which encode tyrosine kinases (7, 11, 26) ; deregulation of enzymatic activity, protein stabilization, and altered subcellular localization have been proposed to explain this requirement. We have found that avian gag (which, unlike mammalian gag, is not myristoylated [8] ) results in partitioning of P47gag-crk into both the membrane and cytosolic fractions, although the majority of the protein is found on the membrane. Our experiments show that v-crk protein that is localized almost exclusively to either the membrane (NSC) or cytosol (SHB) cannot fully transform cells. Phosphotyrosine-containing crk-binding proteins are found in both compartments (21a; see above). We assume that increased phosphotyrosine levels on these proteins are due to interaction with the v-crk protein and that the gag-deleted mutants cannot interact productively with all of the cellular substrate proteins owing to their subcellular localization.
A problem with the replicating retroviral expression system used in these studies is the high viral mutation rate and apparently strong selection for transforming viruses. This leads to a lower percentage of cells expressing nontransforming mutants than the wt and to frequent generation of fully transforming revertants or pseudorevertants from lesstransforming parental mutants. The small percentage of cells expressing nontransforming or weakly transforming mutant proteins made it impossible to assay these mutants for crk-associated tyrosine and serine-threonine kinase activities as previously observed with the wt strain (20, 21, 21a) , since even with highly expressed wt v-crk these activities are relatively low and difficult to detect.
These problems with the retroviral system can be circumvented in the future by expression of mutant genes in mammalian cell lines and by in vitro reconstitution experiments with mutant crk proteins. wt v-crk can transform murine 3T3 cells and rat 3Y1 cells when highly expressed via an integrated selectable vector, and these crk-expressing cell lines have similar biochemical properties to CT10-infected CEF (C. Marshall and H. Hanafusa, unpublished data). Mutant crk genes could be expressed at levels comparable to wt v-crk in mammalian cell lines, allowing a direct comparison. More promising is the finding that v-crk protein expressed in bacteria, or in insect cells via a baculovirus vector, can bind to the phosphotyrosine-containing proteins and to the tyrosine kinase activity of v-crk-transformed cells (21a; Matsuda and Hanafusa, submitted). The nontransforming mutants described here should prove extremely useful in such reconstitution experiments to elucidate the functions of the SH2 and SH3 domains and to identify the proteins whose binding to crk is required for transforming activity.
